October 30 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Monday its non-consolidated net profit rose to 39.1 million levs ($10.4 million/9.3 million euro) in the first nine months of 2017, from 37.5 million levs in the like period of 2016.